GD2 Antibody
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Clinical Trial on Autologous NK Cells Combined With GD2 Monoclonal Antibody in the Treatment of Children With Newly Diagnosed High-risk or Relapsed/Refractory Neuroblastoma (NCT06948994) | Guangzhou Women and Children's Medical Center | 2025-05-01 |
Track GD2 Antibody automatically
Every clearance here is in the API, with alerts when new ones post.